11-45909816-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004813.4(PEX16):​c.*438C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0137 in 530,004 control chromosomes in the GnomAD database, including 214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 109 hom., cov: 34)
Exomes 𝑓: 0.010 ( 105 hom. )

Consequence

PEX16
NM_004813.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.562

Publications

2 publications found
Variant links:
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 8A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • peroxisome biogenesis disorder 8B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-45909816-G-A is Benign according to our data. Variant chr11-45909816-G-A is described in ClinVar as [Benign]. Clinvar id is 304775.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0616 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX16NM_004813.4 linkc.*438C>T 3_prime_UTR_variant Exon 11 of 11 ENST00000378750.10 NP_004804.2 Q9Y5Y5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX16ENST00000378750.10 linkc.*438C>T 3_prime_UTR_variant Exon 11 of 11 1 NM_004813.4 ENSP00000368024.5 Q9Y5Y5-1
PEX16ENST00000241041.7 linkc.*273C>T 3_prime_UTR_variant Exon 11 of 11 1 ENSP00000241041.3 Q9Y5Y5-2

Frequencies

GnomAD3 genomes
AF:
0.0218
AC:
3317
AN:
152228
Hom.:
109
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0638
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00818
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.0321
Gnomad SAS
AF:
0.0505
Gnomad FIN
AF:
0.00273
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.0196
GnomAD4 exome
AF:
0.0104
AC:
3936
AN:
377658
Hom.:
105
Cov.:
0
AF XY:
0.0117
AC XY:
2314
AN XY:
197708
show subpopulations
African (AFR)
AF:
0.0674
AC:
748
AN:
11100
American (AMR)
AF:
0.00436
AC:
71
AN:
16290
Ashkenazi Jewish (ASJ)
AF:
0.00229
AC:
27
AN:
11816
East Asian (EAS)
AF:
0.0314
AC:
804
AN:
25574
South Asian (SAS)
AF:
0.0425
AC:
1785
AN:
42022
European-Finnish (FIN)
AF:
0.00345
AC:
80
AN:
23186
Middle Eastern (MID)
AF:
0.00531
AC:
9
AN:
1696
European-Non Finnish (NFE)
AF:
0.000724
AC:
162
AN:
223882
Other (OTH)
AF:
0.0113
AC:
250
AN:
22092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
176
353
529
706
882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0218
AC:
3314
AN:
152346
Hom.:
109
Cov.:
34
AF XY:
0.0220
AC XY:
1640
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0636
AC:
2644
AN:
41576
American (AMR)
AF:
0.00817
AC:
125
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.0318
AC:
165
AN:
5188
South Asian (SAS)
AF:
0.0503
AC:
243
AN:
4832
European-Finnish (FIN)
AF:
0.00273
AC:
29
AN:
10628
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.000720
AC:
49
AN:
68024
Other (OTH)
AF:
0.0194
AC:
41
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
165
331
496
662
827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0159
Hom.:
19
Bravo
AF:
0.0231
Asia WGS
AF:
0.0870
AC:
300
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder 8A (Zellweger) Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.81
DANN
Benign
0.72
PhyloP100
-0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2280328; hg19: chr11-45931367; API